Cash and Short Term Investments (Annual) Chart

Historical Cash and Short Term Investments (Annual) Data

View and export this data back to 2019. Start Trial.
Date Value
December 31, 2025 148.46M
December 31, 2024 120.19M
December 31, 2023 110.41M
December 31, 2022 181.75M
Date Value
December 31, 2021 132.90M
December 31, 2020 9.778M
December 31, 2019 3.491M

Cash and Short Term Investments Definition

Represents the sum of cash and short term investments.

Read full definition.

Cash and Short Term Investments (Annual) Range, Past 5 Years

View Cash and Short Term Investments (Annual) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash and Short Term Investments (Annual) Benchmarks

View Cash and Short Term Investments (Annual) Benchmarks
Start Trial
Replimune Group, Inc. 268.89M
Korsana Biosciences, Inc. 3.24M
IRulya Therapeutics, Inc. 17.75M
Q32 Bio, Inc. 48.30M
Bridgebio Oncology Therapeutics, Inc. 425.46M